How could the translation of nanotechnology-based therapies revolutionize cutaneous leishmaniasis treatments?

Abstract

Discussing leishmaniasis involves addressing a neglected tropical disease that, to this day, researchers have not succeeded in replacing first-line treatments proposed over a century ago. To explore how nanomedicine might impact its effective treatment, we must first take a look at the specific characteristics of this disease.